These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 27752872)

  • 1. Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.
    Lesko CR; Tong W; Moore RD; Lau B
    AIDS Behav; 2017 Apr; 21(4):1016-1024. PubMed ID: 27752872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.
    Calkins KL; Lesko CR; Chander G; Moore RD; Lau B
    J Acquir Immune Defic Syndr; 2018 Mar; 77(3):317-324. PubMed ID: 29210833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV Care Continuum: Changes over Time in Retention in Care and Viral Suppression.
    Yehia BR; Stephens-Shields AJ; Fleishman JA; Berry SA; Agwu AL; Metlay JP; Moore RD; Christopher Mathews W; Nijhawan A; Rutstein R; Gaur AH; Gebo KA;
    PLoS One; 2015; 10(6):e0129376. PubMed ID: 26086089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDU.
    Lesko CR; Edwards JK; Moore RD; Lau B
    AIDS; 2016 Sep; 30(14):2227-34. PubMed ID: 27314178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time Spent with HIV Viral Load > 1500 Copies/mL Among Persons Engaged in Continuity HIV Care in an Urban Clinic in the United States, 2010-2015.
    Lesko CR; Lau B; Chander G; Moore RD
    AIDS Behav; 2018 Nov; 22(11):3443-3450. PubMed ID: 29541913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study.
    Small W; Milloy MJ; McNeil R; Maher L; Kerr T
    AIDS Res Ther; 2016; 13():26. PubMed ID: 27462360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
    Miller WC; Hoffman IF; Hanscom BS; Ha TV; Dumchev K; Djoerban Z; Rose SM; Latkin CA; Metzger DS; Lancaster KE; Go VF; Dvoriak S; Mollan KR; Reifeis SA; Piwowar-Manning EM; Richardson P; Hudgens MG; Hamilton EL; Sugarman J; Eshleman SH; Susami H; Chu VA; Djauzi S; Kiriazova T; Bui DD; Strathdee SA; Burns DN
    Lancet; 2018 Sep; 392(10149):747-759. PubMed ID: 30191830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.
    Lucas GM; Chaisson RE; Moore RD
    Ann Intern Med; 1999 Jul; 131(2):81-7. PubMed ID: 10419445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
    Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
    Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the care cascade after antiretroviral therapy initiation in Latin America.
    Wolff MJ; Cortes CP; Mejìa FA; Padgett D; Belaunzarán-Zamudio P; Grinsztejn B; Giganti MJ; McGowan CC; Rebeiro PF;
    Int J STD AIDS; 2018 Jan; 29(1):4-12. PubMed ID: 28618980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective "test-and-treat" demonstration project among people who inject drugs in Vietnam.
    Nguyen HH; Bui DD; Dinh TT; Pham LQ; Nguyen VT; Tran TH; Pham TH; Nguyen SM; Suthar AB; Do NT; Ford N; Lo YR; Nguyen LH; Giang LM; Kato M;
    J Int AIDS Soc; 2018 Jul; 21(7):e25151. PubMed ID: 29984473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with sustained virologic suppression in patients receiving antiretroviral therapy in an urban HIV care clinic.
    Purkayastha T; Wasi F; Shuter J
    AIDS Patient Care STDS; 2005 Dec; 19(12):785-93. PubMed ID: 16375610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of HIV transmission at each step of the HIV care continuum among people who inject drugs: a modeling study.
    Escudero DJ; Lurie MN; Mayer KH; King M; Galea S; Friedman SR; Marshall BDL
    BMC Public Health; 2017 Jul; 17(1):614. PubMed ID: 28738861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV treatment outcomes among people who inject drugs in Victoria, Australia.
    Walsh N; Mijch A; Watson K; Wand H; Fairley CK; McNeil J; Crofts N; Maher L
    BMC Infect Dis; 2014 Dec; 14():707. PubMed ID: 25523753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus transmission at each step of the care continuum in the United States.
    Skarbinski J; Rosenberg E; Paz-Bailey G; Hall HI; Rose CE; Viall AH; Fagan JL; Lansky A; Mermin JH
    JAMA Intern Med; 2015 Apr; 175(4):588-96. PubMed ID: 25706928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between methamphetamine use and lack of viral suppression among a cohort of HIV-positive persons who inject drugs in Hai Phong, Vietnam.
    Feelemyer J; Arasteh K; Huong DT; Oanh KTH; Khue PM; Giang HT; Thanh NTT; Moles JP; Vinh VH; Vallo R; Quillet C; Rapoud D; Le SM; Michel L; Laureillard D; Nagot N; Des Jarlais DC;
    AIDS; 2020 Nov; 34(13):1875-1882. PubMed ID: 32910061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.
    Lucas GM; Mullen BA; Weidle PJ; Hader S; McCaul ME; Moore RD
    Clin Infect Dis; 2006 Jun; 42(11):1628-35. PubMed ID: 16652321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of an intensive case management program for injection drug users on antiretroviral therapy in St. Petersburg, Russia.
    Shaboltas AV; Skochilov RV; Brown LB; Elharrar VN; Kozlov AP; Hoffman IF
    Harm Reduct J; 2013 Sep; 10():15. PubMed ID: 24006958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of substance use in HIV care cascade outcomes among people who inject drugs in Russia.
    Idrisov B; Lunze K; Cheng DM; Blokhina E; Gnatienko N; Quinn E; Bridden C; Walley AY; Bryant KJ; Lioznov D; Krupitsky E; Samet JH
    Addict Sci Clin Pract; 2017 Dec; 12(1):30. PubMed ID: 29198185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor retention in care one-year after viral suppression: a significant predictor of viral rebound.
    Crawford TN
    AIDS Care; 2014; 26(11):1393-9. PubMed ID: 24848440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.